Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk of Anaphylactoid Reactions of Iopromide After Intra-arterial Administration

NCT03622801 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT03622801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03622801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk of Anaphylactoid Reactions of Iopromide After Intra-arterial Administration
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
October 12, 2018
Completion date
February 14, 2019
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contrast medium